Seeing CNV sooner

New research by a multinational team suggests that noninvasive imaging of CC chemokine receptor 3 could help detect wet age-related macular degeneration before retinal damage occurs.¹ This would allow earlier therapeutic intervention, which is important because retinal damage is not always reversible.

In addition, the researchers think CC chemokine receptor 3 (CCR3) inhibitors could be combined with VEGF-A inhibitors to treat the disease-even if the former are unlikely to displace the latter...